Onglyza Linked to Pancreatic Cancer
The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication,
Read MoreFaulty Pharmaceutical Drugs Resources
Drug Database
The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication,
Read MoreTakeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims of hiding its Actos diabetes medicine’s
Read MoreA recent study suggests that Zofran side effects may be fatal for some children. The study examines two children who were
Read MoreZofran Lawsuit Update Several medical studies have highlighted the risk of Zofran side effects, including cleft palate, cleft lip and
Read MoreThe following table lists the NDCs and labelers of ZOFRAN: NDC Trade Name Labeler Name 55154-1132 ZOFRAN CARDINAL HEALTH PHARMACEUTICAL
Read MoreAttention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has
Read MoreGlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read MoreBoehringer Ingelheim Settles US Pradaxa Litigation For $650 Million Boehringer Ingelheim will pay $650 million in a “comprehensive settlement” of
Read MoreThe FDA has issued a warning of an increased risk of high-grade prostate cancer with Avodart (generic:dutasteride), currently approved to
Read MoreIn 2012, analysis of clinical trial results prompted the U.S. Food and Drug Administration to change the labels of the
Read More